• 1. Exchangeability of amino acid residues with similar physicochemical properties in coiled-coil interactions?
  Guiying Zhang,Maosheng Cheng,Yanni Li,Keliang Liu,Lifeng Cai Chem. Commun., 2013,49, 11086-11088
• 2. Excellent mechanical performance and enhanced dielectric properties of OBC/SiO2 elastomeric nanocomposites: effect of dispersion of the SiO2 nanoparticles?
  Xing Zhao,Lu Bai,Rui-Ying Bao,Zheng-Ying Liu,Ming-Bo Yang,Wei Yang RSC Adv., 2017,7, 46297-46305
• 3. Evidence of CO2 molecule acting as an electron acceptor on a nanoporous metal–organic-framework MIL-53 or Cr3+(OH)(O2C–C6H4–CO2)?
  Alexandre Vimont,Arnaud Travert,Philippe Bazin,Jean-Claude Lavalley,Marco Daturi,Christian Serre,Gérard Férey,Sandrine Bourrelly,Philip L. Llewellyn Chem. Commun., 2007, 3291-3293
• 4. Fe3O4 nanoclusters highly dispersed on a porous graphene support as an additive for improving the hydrogen storage properties of LiBH4?
  Guang Xu,Wei Zhang,Ying Zhang,Xiaoxia Zhao,Ping Wen,Di Ma RSC Adv., 2018,8, 19353-19361
• 5. Evidence of field induced slow magnetic relaxation in cis-[Co(hfac)2(H2O)2] exhibiting tri-axial anisotropy with a negative axial component?
  Denis V. Korchagin,Elena A. Yureva,Alexander V. Akimov,Eugenii Ya. Misochko,Gennady V. Shilov,Artem D. Talantsev,Roman B. Morgunov,Alexander A. Shakin,Sergey M. Aldoshin,Boris S. Tsukerblat Dalton Trans., 2017,46, 7540-7548

• Solvents and Organic Chemicals Organic Compounds Benzenoids Benzene and substituted derivatives Aminobenzoic acids and derivatives
• Solvents and Organic Chemicals Organic Compounds Benzenoids Benzene and substituted derivatives Benzoic acids and derivatives Aminobenzoic acids and derivatives

Introduction to 4-Chloro-2-(methylamino)benzoic acid (CAS No. 54675-18-2)

4-Chloro-2-(methylamino)benzoic acid, identified by its Chemical Abstracts Service (CAS) number 54675-18-2, is a significant compound in the realm of pharmaceutical and chemical research. This compound belongs to the benzoic acid derivatives, a class of molecules widely recognized for their diverse biological activities and therapeutic potential. The presence of both chloro and methylamino substituents in its structure imparts unique chemical properties that make it a valuable intermediate in the synthesis of various pharmacologically active agents.

The structural framework of 4-Chloro-2-(methylamino)benzoic acid consists of a benzene ring substituted at the 4-position with a chlorine atom and at the 2-position with a methylamino group. This arrangement not only influences its electronic distribution but also affects its reactivity and interaction with biological targets. The chloro group, being electron-withdrawing, can modulate the electronic properties of the aromatic ring, while the methylamino group, on the other hand, introduces basicity and potential hydrogen bonding capabilities. Such features are crucial in designing molecules that can selectively interact with biological systems.

In recent years, there has been growing interest in 4-Chloro-2-(methylamino)benzoic acid due to its role as a key intermediate in the development of novel therapeutic agents. One of the most compelling areas of research involves its application in the synthesis of small-molecule inhibitors targeting various enzymatic pathways implicated in human diseases. For instance, studies have demonstrated its utility in generating compounds that exhibit inhibitory effects on enzymes such as cyclooxygenase (COX) and lipoxygenase (LOX), which are involved in inflammation and oxidative stress.

Moreover, the compound has shown promise in the development of anticancer agents. The benzoic acid core is a common motif in many chemotherapeutic drugs, and modifications at specific positions can lead to enhanced efficacy and reduced toxicity. Research published in recent journals indicates that derivatives of 4-Chloro-2-(methylamino)benzoic acid can interfere with critical signaling pathways in cancer cells, such as those involving tyrosine kinases and transcription factors. These findings highlight the compound's potential as a scaffold for designing next-generation anticancer therapies.

Another area where 4-Chloro-2-(methylamino)benzoic acid has garnered attention is in the field of neurology. The ability of this compound to cross the blood-brain barrier and interact with central nervous system (CNS) receptors has made it a candidate for treating neurological disorders such as Alzheimer's disease and Parkinson's disease. Preclinical studies have suggested that certain analogs derived from 4-Chloro-2-(methylamino)benzoic acid can modulate neurotransmitter release and receptor activity, offering a potential therapeutic strategy for these debilitating conditions.

The synthetic chemistry associated with 4-Chloro-2-(methylamino)benzoic acid is also noteworthy. The introduction of functional groups like chloro and methylamino requires precise control over reaction conditions to ensure high yield and purity. Advanced synthetic methodologies, including catalytic hydrogenation and palladium-catalyzed cross-coupling reactions, have been employed to optimize the synthesis of this compound. These techniques not only improve efficiency but also allow for greater flexibility in modifying its structure for tailored biological activities.

From an industrial perspective, 4-Chloro-2-(methylamino)benzoic acid is valued for its scalability in production. Pharmaceutical companies often seek intermediates that can be synthesized cost-effectively on an industrial scale without compromising quality. The well-established synthetic routes for 4-Chloro-2-(methylamino)benzoic acid make it an attractive choice for large-scale manufacturing processes. This scalability is crucial for ensuring an adequate supply of precursor materials needed for drug development programs.

The safety profile of 4-Chloro-2-(methylamino)benzoic acid is another important consideration. While it is not classified as a hazardous material under standard regulatory guidelines, proper handling procedures must be followed to minimize exposure risks during synthesis and handling. Personal protective equipment (PPE), such as gloves, goggles, and lab coats, should be used when working with this compound to prevent skin contact or inhalation of dust particles.

In conclusion, 4-Chloro-2-(methylamino)benzoic acid (CAS No. 54675-18-2) is a versatile and valuable compound with significant applications in pharmaceutical research and drug development. Its unique structural features make it a promising scaffold for designing novel therapeutic agents targeting various diseases, including cancer and neurological disorders. Ongoing research continues to explore new derivatives and applications of this compound, underscoring its importance in advancing medical science.

• 13278-36-9(N-(3-Chlorophenyl)anthranilic Acid)
• 68917-49-7(4-Chloro-2-(dimethylamino)benzoic acid)
• 13278-35-8(2-(4-Chloroanilino)benzoic acid)
• 64808-48-6(Lobenzarit Disodium)
• 19218-88-3(4-Chloro-2-(phenylamino)benzoic acid)
• 17870-85-8(Benzoic acid,4-chloro-2-[(3-chlorophenyl)amino]-)
• 90656-45-4( )
• 63329-53-3(Lobenzarit)
• 18201-65-5(Dichlorophenyl-ABA)
• 28294-55-5(1,4-Benzenedicarboxylicacid, 2,5-bis[(3-chlorophenyl)amino]-)